In light of these results, our finding that highly elevated anti-TPO titers were measured in 79% of the long COVID patients compared to the 18.5% prevalence in the CC group, even 23.1 and 18.2 months after COVID-19, respectively, strongly suggests a clear association between highly elevated anti-TPO titers and long COVID. This evidence concerns the gene TPO and COVID-19.